Amy Dockser Marcus on Muck Rack

Amy Dockser Marcus

Verified
As seen in: Techfluential by Deloitte, The Information, MSN, Valor Econômico, TIME, The Wall Street Journal, The Wall Street Journal (China), Yahoo Finance, MarketWatch, Substack, The New Yorker, The Toronto Star and
Reporter at @theinformation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amy Dockser

Contact Amy Dockser, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Longevity Startups Have a Conundrum: Can They Sell Longevity Drugs?

|
By Amy Dockser Marcus Verified
| The Information Verified
In many ways, these are the best of times for Silicon Valley’s buzziest crop of longevity startups and their pursuit of drugs that can reverse aging. NewLimit, a cell reprogramming company co-founded in 2022 by Coinbase CEO Brian Armstrong, announced earlier this month that it had raised another $435 million and plans to start testing a drug in humans next year. In all, it has collected over $630 million in funding.
Open in Who Shared Issue with article?

A Complicated Comeback for Stanford’s Ex-President

|
By Amy Dockser Marcus Verified
| The Information Verified
Welcome, Weekenders! In this newsletter: • The Big Read: The tech elite’s go-to real estate broker? The mayor’s brother • Crypto: Inside crypto’s Washington command center • Lists: 20 great books for summer 2026 • Plus, Recommendations—our weekly pop culture picks: “John Kiriakou’s Dead Drop,” “Returning” and “The Testaments” Lately, it seems that Marc Tessier-Lavigne has been popping up everywhere.
Open in Who Shared Issue with article?

Can AI Help a Tech CEO Cure His Spouse’s Brain Cancer?

|
By Amy Dockser Marcus Verified
| The Information Verified
When Alicia Kalogeropoulos was first diagnosed in 2018 with brain cancer, she underwent surgery, and three years later, she enrolled in a clinical trial for a pill that worked to keep her disease in check for years. In February, Alicia and her husband Alex received grim news: Her tumor had returned. Her physicians at Memorial Sloan Kettering Cancer Center in New York advised Alicia, 35, that her options were another surgery, likely followed by chemotherapy and radiation.
Open in Who Shared Issue with article?
See all 313 licensed articles (328 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified